We and others have shown that IRES-mediated translation of oncogenic mRNAs such as c-myc and IGF1R may be responsible for, or contribute to resistance to therapy and enhanced survival of malignant cells under suboptimal microenvironmental conditions such as those to which tumor cells are exposed in vivo [16–18]. This evidence concerns the gene MYC and neoplasm.